#France #Boston #Connected Health #Withings #profitability

Withings Achieves Remarkable Profitability in 2025

In a monumental announcement, French healthtech company Withings has officially reached full-year profitability for the year 2025. This success marks a significant turning point for the firm, given that it aims to integrate connected health technology into routine medical care rather than just casual consumer gadgetry. Since its acquisition by co-founder Eric Carreel in 2018, after being sold to Nokia in 2016, Withings has focused on pivoting the connected health narrative.

The Growth of Withings

Withings has demonstrated impressive growth, with an astounding 90% increase in global revenue. As of 2025, the U.S. has emerged as its largest market, accounting for 66% of total revenue derived from FDA-cleared medical devices. In a sector where profitability is rare, Withings has firmly established itself as a player that harmonizes scale, clinical credibility, and profitability—a trifecta that has been elusive within the connected health landscape.

Co-founder Eric Carreel expressed that the company has strategically navigated towards the mainstream adoption of health technology, especially in light of current discussions around longevity, prevention, and remote patient monitoring. Withings has positioned itself well over the past years, emphasizing not just functionality but also clinical integration, showcasing their ability to adapt and thrive in a progressive healthcare environment.

U.S. Market Focus

The U.S. is not just any market for Withings; it is a key driver for the company's revenue growth. Understanding that American consumers expect more than just fitness trackers, Withings has created long-term health companions, garnering trust among its users. A significant investment of €61 million in funding since 2019 has enabled Withings to expand its reach rapidly through its FDA-cleared home devices that provide crucial health data. Notably, their subscription service, Withings+, has seen its revenue nearly double in 2025, underscoring the growing consumer interest in their offerings.

In 2025, Withings crossed 15 million active users, collectively tracking over 1 billion health measurements, indicating a robust engagement rate. Furthermore, a substantial portion of these measurements—approximately 35%—was recorded as clinically relevant data, which is transformative for user health management and medical applications.

Driving Change in Healthcare

Withings Health Solutions, serving B2B agreements to hospitals and health systems, has witnessed exceptional growth. Currently, it enrolls over 740,000 patients in remote monitoring programs, compared to merely 25,500 prior to the buyout by Carreel. This growth is indicative of the trust gained from the medical community. Withings operates on the principle of harnessing continuous patient-generated insights, thereby enhancing the quality of care while also decreasing operational burdens on health providers.

The company stands out not only for its technology but also for its influential role in developing obesity care standards, reinforcing its reputation as a leading device supplier in diabetes and obesity management. Through a commitment to patient retention and engagement, Withings has enabled healthcare partners to achieve device retention rates as high as 92%, significantly outperforming the industry average.

Research and Development Commitment

With a steadfast commitment to research and development, Withings has consistently allocated 20 to 27% of its annual revenue toward R&D—an impressive investment considering that this percentage is far above the consumer electronics industry average. This strategic allocation has translated into an expansive product lineup, equipped with features that cater to clinical needs, with no direct equivalents available in the U.S. market.

The scientific momentum gained since 2018 is substantial, characterized by 31 annual clinical publications in 2025 alone, establishing Withings as an influential entity in connected health research. This trajectory confirms its commitment to improving health outcomes through reliable and robust technology.

Concluding Thoughts

With its remarkable journey, Withings exemplifies how a company's vision can redefine healthcare and consumer expectations. By achieving full-year profitability and establishing itself as a leader in the connected health sector, Withings not only sets a precedent within the industry but also reflects the growing trend of integrating everyday technology into serious health management. As the medical landscape evolves, Withings remains at the forefront, positioning itself as a trusted ally for consumers seeking comprehensive health solutions.

For further information about Withings products and initiatives, visit withings.com.